OSTEOPOROSIS INDUCED IN MICE BY OVERPRODUCTION OF INTERLEUKIN-4

被引:126
|
作者
LEWIS, DB
LIGGITT, HD
EFFMANN, EL
MOTLEY, ST
TEITELBAUM, SL
JEPSEN, KJ
GOLDSTEIN, SA
BONADIO, J
CARPENTER, J
PERLMUTTER, RM
机构
[1] UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195
[2] UNIV WASHINGTON,DEPT COMPARAT MED,SEATTLE,WA 98195
[3] UNIV WASHINGTON,DEPT RADIOL,SEATTLE,WA 98195
[4] UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195
[5] UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195
[6] UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195
[7] WASHINGTON UNIV,DEPT PATHOL,ST LOUIS,MO 63178
[8] CHILDRENS ORTHOPED HOSP,DEPT RADIOL,SEATTLE,WA 98105
[9] UNIV MICHIGAN,DEPT PATHOL,ANN ARBOR,MI 48109
[10] UNIV MICHIGAN,ORTHOPAED RES LAB,ANN ARBOR,MI 48109
关键词
TRANSGENIC MICE; OSTEOBLASTS; OSTEOCLASTS; LCK PROMOTER; OSTEOPENIA;
D O I
10.1073/pnas.90.24.11618
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Osteoporosis is a common disease in which loss of bone mass results in skeletal fragility. The development of therapies for this disorder has been hampered by the lack of a convenient animal model. Here we describe a disorder in bone homeostasis in transgenic mice that inappropriately express the cytokine interleukin 4 (IL-4) under the direction of the lymphocyte-specific proximal promoter for the lck gene. Bone disease in lck-IL-4 mice appeared to result from markedly decreased bone formation by osteoblasts, features strikingly similar to those observed in cases of severe low-turnover human involutional osteoporosis. By 2 months of age, female and male lck-IL-4 mice invariably developed severe osteoporosis of both cortical and trabecular bone. Osteoporosis was observed in two independently derived founder animals, indicating that this phenotype was directly mediated by the IL-4 transgene.
引用
收藏
页码:11618 / 11622
页数:5
相关论文
共 50 条
  • [31] INTERLEUKIN-4 INDUCED MOTILITY IN LYMPHOCYTES-B
    CLINCHY, B
    ELENSTROM, C
    SEVERINSON, E
    MOLLER, G
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (04) : 388 - 388
  • [32] The molecular basis of interleukin-4 induced macrophage fusion
    Helming, L.
    Winter, J.
    Maroof, N.
    Tomasello, E.
    Vivier, E.
    Gordon, S.
    IMMUNOLOGY, 2008, 125 : 4 - 4
  • [33] Differential effects of interleukin-4 in peptide induced autoimmunity
    Deocharan, B
    Marambio, P
    Edelman, M
    Putterman, C
    CLINICAL IMMUNOLOGY, 2003, 108 (02) : 80 - 88
  • [34] A role for interleukin-4 in high dose oral tolerance in mice
    Yoshino, S
    BIOMEDICAL LETTERS, 1997, 55 (218): : 99 - 104
  • [35] Interleukin-4 deficiency does not exacerbate disease in NOD mice
    Wang, B
    Gonzalez, A
    Höglund, P
    Katz, JD
    Benoist, C
    Mathis, D
    DIABETES, 1998, 47 (08) : 1207 - 1211
  • [36] Immunopathologic responses to Aspergillus antigen in interleukin-4 knockout mice
    Kurup, VP
    Guo, J
    Murali, PS
    Choi, H
    Fink, JN
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (06): : 567 - 575
  • [37] INTERLEUKIN-4 INHIBITS BONE METABOLISM IN THE OVARIECTOMIZED (OVX) MICE
    OKADA, Y
    MORIMOTO, I
    URA, K
    NAKANO, Y
    TANAKA, Y
    NISHIDA, S
    KAYAMA, F
    UEDA, S
    NAKAMURA, T
    ETO, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S443 - S443
  • [38] HUMAN INTERLEUKIN-4
    BANCHEREAU, J
    BRIERE, F
    GALIZZI, JP
    MIOSSEC, P
    ROUSSET, F
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1994, 9 (01): : 43 - 53
  • [39] WHICH INTERLEUKIN-4
    NEWMARK, P
    NATURE, 1986, 319 (6055) : 620 - 620
  • [40] Interleukin-4 and listeriosis
    Kaufmann, SHE
    Emoto, M
    Szalay, G
    Barsig, J
    Flesch, IEA
    IMMUNOLOGICAL REVIEWS, 1997, 158 : 95 - 105